Deepti Formulations Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 23-10-2024
- Paid Up Capital ₹ 1.15 M
as on 23-10-2024
- Company Age 34 Year, 1 Day
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.26 M
as on 23-10-2024
- Satisfied Charges ₹ 1.06 Cr
as on 23-10-2024
- Revenue -8.31%
(FY 2023)
- Profit 0.89%
(FY 2023)
- Ebitda 53.90%
(FY 2023)
- Net Worth 13.05%
(FY 2023)
- Total Assets 30.38%
(FY 2023)
About Deepti Formulations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.15 M.
The company currently has active open charges totaling ₹8.26 M. The company has closed loans amounting to ₹1.06 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ashwini Chadda, Dhruv Chadda, and Deepti Chadda serve as directors at the Company.
- CIN/LLPIN
U24231TG1990PTC012122
- Company No.
012122
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Dec 1990
- Date of AGM
04 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Deepti Formulations?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashwini Chadda  | Whole-Time Director | 11-Oct-2003 | Current |
| Dhruv Chadda | Director | 18-Dec-2020 | Current |
| Deepti Chadda | Director | Current |
Financial Performance of Deepti Formulations.
Deepti Formulations Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.31% decrease. The company also saw a slight improvement in profitability, with a 0.89% increase in profit. The company's net worth Soared by an impressive increase of 13.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Deepti Formulations?
In 2023, Deepti Formulations had a promoter holding of 99.83% and a public holding of 0.17%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Espi Industries And Chemicals Pvt LtdActive 47 years 9 monthsAshwini Chadda and Dhruv Chadda are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Andhra Bank Creation Date: 04 Apr 2001 | ₹2.50 M | Open |
Andhra Bank Creation Date: 28 Apr 1999 | ₹2.12 M | Open |
Andhra Bank Creation Date: 20 Nov 1998 | ₹0.75 M | Open |
How Many Employees Work at Deepti Formulations?
Deepti Formulations has a workforce of 36 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Deepti Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Deepti Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
